207_Combined course Presentations

Changing nature of early development trials

• Enrichment strategies: by subtype of by genomic alterations • Novel dose escalation methods applied • Research biopsies • Driving go-no-go decisions based on their ability to provide proof of concept • Trends in increase in the sample size of phase I trials • Expanding cohorts being conducted for multiple purposes